跳至主要内容
临床试验/EUCTR2012-005398-30-IT
EUCTR2012-005398-30-IT进行中(未招募)1 期

Diagnostic efficacy and prognostic method [18F] DOPA-PET/CT instudy of neuroblastoma: comparison with 123I-MIBG scintigraphy - dopa

AZIENDA OSPEDALIERA OSPEDALI GALLIERA0 个研究点目标入组 40 人开始时间: 2013年1月11日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Age > 12 months <18 years
  • - Patients suffering from NB onset with high probability to return in stages 3 and 4 of the disease on the basis of
  • ultrasound or CT images. May also be included with the two-stage amplification of N-MYC
  • - Histological diagnosis of NB
  • - No previous chemotherapy lines with the exception of steroid treatment
  • - written informed consent
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 40
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Comorbidity for other cancers
  • - Hypersensitivity to the active substance or excipients in the radiopharmaceutical.
  • - Any other medical condition at the discretion of the investigator.

研究者

发起方
AZIENDA OSPEDALIERA OSPEDALI GALLIERA

相似试验

Diagnostic efficacy and prognostic method [18F]... | 临床试验